2
RESEARCH METHODOLOGY
28
5
MARKET OVERVIEW
Booming organ donation initiatives and tech innovations drive market growth despite cost and supply challenges.
51
5.2.1.1
GROWING GERIATRIC POPULATION AND SUBSEQUENT GROWTH IN CASES OF MULTIPLE ORGAN FAILURE
5.2.1.2
INCREASING INITIATIVES TO PROMOTE PUBLIC AWARENESS AND ENCOURAGE ORGAN DONATION
5.2.1.3
RISING NUMBER OF ORGAN DONORS AND GROWING ADOPTION OF SOLID ORGAN TRANSPLANTATION PROCEDURES
5.2.2.1
HIGH COST OF ORGAN TRANSPLANTATION
5.2.2.2
RELIGIOUS CONCERNS AND MISCONCEPTIONS ASSOCIATED WITH ORGAN DONATION
5.2.3.1
GROWING HEALTHCARE INVESTMENTS
5.2.4.1
SIGNIFICANT GAP BETWEEN NUMBER OF ORGANS DONATED AND ORGANS REQUIRED ANNUALLY
5.2.4.2
DEVELOPMENT OF ARTIFICIAL ORGANS
5.6
SUPPLY CHAIN ANALYSIS
5.7.1
PATENT PUBLICATION TRENDS FOR ORGAN PRESERVATION MARKET
5.7.2
TOP APPLICANTS (COMPANIES) OF ORGAN PRESERVATION PATENTS
5.7.3
JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ORGAN PRESERVATION MARKET
5.8.1.1
MACHINE PERFUSION
5.8.2
ADJACENT TECHNOLOGIES
5.8.2.1
CRYOPRESERVATION & VITRIFICATION
5.8.3
COMPLEMENTARY TECHNOLOGIES
5.8.3.1
TEMPERATURE MONITORING DEVICES
5.10
KEY CONFERENCES AND EVENTS IN 2025–2026
5.11
REGULATORY LANDSCAPE
5.11.1
REGULATORY ANALYSIS
5.11.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12
PORTER’S FIVE FORCES ANALYSIS
5.12.1
THREAT FROM NEW ENTRANTS
5.12.2
THREAT FROM SUBSTITUTES
5.12.3
BARGAINING POWER OF SUPPLIERS
5.12.4
BARGAINING POWER OF BUYERS
5.12.5
INTENSITY OF COMPETITIVE RIVALRY
5.13
KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.14
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.16
INVESTMENT AND FUNDING SCENARIO
5.17
REIMBURSEMENT SCENARIO
5.18
IMPACT OF AI ON ORGAN PRESERVATION MARKET
5.19
END USER EXPECTATIONS IN ORGAN PRESERVATION MARKET
5.20
IMPACT OF 2025 US TARIFFS
5.20.3
PRICE IMPACT ANALYSIS
5.20.4
IMPACT ON END USERS
6
ORGAN PRESERVATION MARKET, BY SOLUTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
81
6.2
UNIVERSITY OF WISCONSIN
6.2.1
METABOLICALLY INERT SUBSTRATES ENABLE BETTER TRANSPLANTATION OUTCOMES
6.3.1
INDICATED FOR PERFUSION AND FLUSHING OF KIDNEYS, LIVER, PANCREAS, AND HEART
6.4.1
LAUNCH OF PERFADEX PLUS TO DRIVE MARKET
7
ORGAN PRESERVATION MARKET, BY TECHNIQUE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 9 Data Tables
89
7.2.1
MOST WIDELY ADOPTED ORGAN PRESERVATION TECHNIQUE
7.3
HYPOTHERMIC MACHINE PERFUSION
7.3.1
ADVANTAGES ASSOCIATED WITH HYPOTHERMIC MACHINE PERFUSION TO DRIVE DEMAND
7.4
NORMOTHERMIC MACHINE PERFUSION
7.4.1
PROVIDES VIABLE ENVIRONMENT FOR ORGAN PRESERVATION, VIABILITY, AND REPAIR PRIOR TO TRANSPLANTATION
8
ORGAN PRESERVATION MARKET, BY ORGAN TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
98
8.2.1
MOST TRANSPLANTED ORGANS GLOBALLY
8.3.1
RISING PREVALENCE OF LIVER DISEASE AND GROWING CASES OF LIVER FAILURE TO DRIVE DEMAND FOR LIVER TRANSPLANTATION PROCEDURES
8.4.1
GROWTH IN COPD INCIDENCE TO BOOST DEMAND FOR PRESERVATION TECHNIQUES AND PRODUCTS
8.5.1
ADVANCEMENTS IN HEART PRESERVATION TECHNIQUES TO DRIVE MARKET
9
ORGAN PRESERVATION MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
106
9.2
ORGAN TRANSPLANT CENTERS
9.2.1
MAJOR END USERS OF ORGAN PRESERVATION SOLUTIONS
9.3.1
INCREASING CASES OF ACCIDENTAL INJURIES AND CHRONIC DISEASES TO DRIVE MARKET
9.4.1
INCREASING PREVALENCE OF END-STAGE DISEASES AND ORGAN FAILURE TO DRIVE MARKET
10
ORGAN PRESERVATION MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 107 Data Tables.
111
10.2.1
MACROECONOMIC OUTLOOK
10.2.2.1
GROWING CASES OF ORGAN FAILURE AND UNDERLYING DISEASES TO DRIVE DEMAND
10.2.3.1
IMPROVED ORGAN DONATION RATES TO DRIVE GROWTH
10.3.1
MACROECONOMIC OUTLOOK
10.3.2.1
GROWING PATIENT POPULATION TO DRIVE DEMAND
10.3.3.1
INCREASING NUMBER OF ORGAN TRANSPLANTS AND ORGAN DONOR REGISTRATIONS TO DRIVE GROWTH
10.3.4.1
INCREASING DISEASE/DISORDER PREVALENCE AND FAVORABLE REGULATIONS TO DRIVE DEMAND
10.3.5.1
HIGH DONATION RATES TO DRIVE GROWTH
10.3.6.1
SURGE IN DONOR NUMBERS AND TECHNOLOGICAL INNOVATION TO DRIVE GROWTH
10.4.1
MACROECONOMIC OUTLOOK
10.4.2.1
GROWING AWARENESS AND ADOPTION OF LAWS FAVORING ORGAN DONATION TO DRIVE MARKET
10.4.3.1
NATIONWIDE AWARENESS CAMPAIGNS AND PROMOTED OPT-IN REGISTRATION TO DRIVE GROWTH
10.4.4.1
GROWING NUMBER OF INITIATIVES TO INCREASE PUBLIC AWARENESS TO DRIVE MARKET
10.4.5.1
ENHANCED HOSPITAL-BASED DONATION PROGRAMS TO DRIVE GROWTH
10.4.6.1
IMPROVED DONOR REGISTRATION SYSTEMS TO DRIVE GROWTH
10.4.7
REST OF ASIA PACIFIC
10.5.1
MACROECONOMIC OUTLOOK
10.5.2.1
DIGITALIZATION OF DONOR REGISTRIES TO DRIVE GROWTH
10.5.3.1
ORGAN DONATION EFFORTS SUPPORTED BY CENTRALIZED TRANSPLANT REGISTRY AND NATIONAL COORDINATION TO DRIVE GROWTH
10.5.4
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
IMPLEMENTATION OF GOVERNMENT INITIATIVES AND POLICIES TO DRIVE MARKET
10.6.2
MACROECONOMIC OUTLOOK
10.7.1
STRONG ORGAN PRESERVATION THROUGH INCENTIVES, INFRASTRUCTURE, AND PUBLIC AWARENESS TO DRIVE GROWTH
10.7.2
MACROECONOMIC OUTLOOK
11
COMPETITIVE LANDSCAPE
Identify key players' winning strategies and market shares shaping the competitive landscape.
172
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3
REVENUE ANALYSIS, 2022–2024
11.4
MARKET SHARE ANALYSIS
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1
COMPANY FOOTPRINT
11.5.5.2
SOLUTION FOOTPRINT
11.5.5.3
TECHNIQUE FOOTPRINT
11.5.5.4
END USER FOOTPRINT
11.5.5.5
REGION FOOTPRINT
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1
PROGRESSIVE COMPANIES
11.6.2
RESPONSIVE COMPANIES
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1
LIST OF KEY STARTUPS/SMES
11.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.7
COMPANY VALUATION AND FINANCIAL METRICS
11.8
BRAND/PRODUCT COMPARISON
11.9
COMPETITIVE SCENARIO
11.9.1
PRODUCT LAUNCHES & APPROVALS
11.9.3
OTHER DEVELOPMENTS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
191
12.1.1
PARAGONIX TECHNOLOGIES, INC.
12.1.1.1
BUSINESS OVERVIEW
12.1.1.2
PRODUCTS OFFERED
12.1.1.3
RECENT DEVELOPMENTS
12.1.2
XVIVO PERFUSION AB
12.1.3
DR. FRANZ KÖHLER CHEMIE GMBH
12.1.4
ESSENTIAL PHARMACEUTICALS, LLC (SUBSIDIARY OF ACCORD HEALTHCARE)
12.1.7
21ST CENTURY MEDICINE
12.1.8
BIOLIFE SOLUTIONS, INC.
12.1.9
BRIDGE TO LIFE LIMITED
12.1.10
WATERS MEDICAL SYSTEMS LLC
12.2.1
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
12.2.2
PRESERVATION SOLUTIONS, INC.
12.2.4
TRANSPLANT BIOMEDICALS
12.2.5
INSTITUT GEORGES LOPEZ
12.2.6
GLOBAL TRANSPLANT SOLUTIONS
12.2.8
ORGAN PRESERVATION SOLUTIONS LTD.
12.2.12
VASCULAR PERFUSION SOLUTIONS, INC.
12.2.14
TAIYO NIPPON SANSO CORPORATION
13.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
AVAILABLE CUSTOMIZATIONS
TABLE 1
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021–2024
TABLE 2
GROWTH IN GERIATRIC POPULATION (ABOVE 65 AGE GROUP), BY REGION, 2019 VS. 2050 (MILLION)
TABLE 3
NUMBER OF ORGAN DONATIONS, 2020
TABLE 4
COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)
TABLE 5
AVERAGE SELLING PRICE RANGE OF ORGAN PRESERVATION SOLUTIONS, BY KEY PLAYERS, 2023–2024
TABLE 6
AVERAGE SELLING PRICE RANGE OF CUSTODIOL SOLUTIONS FOR ORGAN PRESERVATION SOLUTIONS IN KEY REGIONS, 2022–2024
TABLE 7
ORGAN PRESERVATION MARKET: LIST OF MAJOR PATENTS, 2020–2021
TABLE 8
IMPORT DATA OF ORGAN PRESERVATION FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 9
EXPORT DATA OF ORGAN PRESERVATION FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 10
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 SOLUTIONS (%)
TABLE 15
KEY BUYING CRITERIA FOR TOP 3 SOLUTIONS
TABLE 16
CASE STUDY 1: PRESERVATION OF MARGINAL LIVER USING NORMOTHERMIC MACHINE PERFUSION (NMP)
TABLE 17
CASE STUDY 2: HYPOTHERMIC MACHINE PERFUSION FOR EXTENDED CRITERIA KIDNEY TRANSPLANT
TABLE 18
CASE STUDY 3: USE OF PORTABLE NORMOTHERMIC PERFUSION FOR HEART TRANSPLANTATION
TABLE 19
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 20
ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 21
ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 22
ORGAN PRESERVATION MARKET FOR UW SOLUTIONS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 23
ORGAN PRESERVATION MARKET FOR CUSTODIOL HTK SOLUTIONS, BY COUNTRY/ REGION, 2023–2030 (USD MILLION)
TABLE 24
ORGAN PRESERVATION MARKET FOR PERFADEX SOLUTIONS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 25
OTHER ORGAN PRESERVATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 26
COMPARISON OF METHODS USED FOR ORGAN PRESERVATION
TABLE 27
ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 28
ORGAN PRESERVATION TECHNIQUE MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 29
STATIC COLD STORAGE: ADVANTAGES AND DISADVANTAGES
TABLE 30
ORGAN PRESERVATION MARKET FOR STATIC COLD STORAGE, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 31
HYPOTHERMIC MACHINE PERFUSION: ADVANTAGES AND DISADVANTAGES
TABLE 32
ORGAN PRESERVATION MARKET FOR HYPOTHERMIC MACHINE PERFUSION, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 33
NORMOTHERMIC MACHINE PERFUSION: ADVANTAGES AND DISADVANTAGES
TABLE 34
ORGAN PRESERVATION MARKET FOR NORMOTHERMIC MACHINE PERFUSION, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 35
ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 36
KIDNEY PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 37
LIVER PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 38
LUNG PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 39
HEART PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 40
OTHER ORGAN PRESERVATION MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 41
ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 42
ORGAN PRESERVATION MARKET FOR ORGAN TRANSPLANT CENTERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 43
ORGAN PRESERVATION MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 44
ORGAN PRESERVATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY/REGION, 2023–2030 (USD MILLION)
TABLE 45
ORGAN PRESERVATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 48
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 49
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 50
NORTH AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 51
US: KEY MACROINDICATORS
TABLE 52
WAITING LIST FOR ORGAN TRANSPLANTS AS OF JANUARY 2022
TABLE 53
US: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 54
US: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 55
US: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 56
US: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 57
CANADA: KEY MACROINDICATORS
TABLE 58
CANADA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 59
CANADA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 60
CANADA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 61
CANADA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 62
EUROPE: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 64
EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 65
EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 66
EUROPE: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 67
GERMANY: KEY MACROINDICATORS
TABLE 68
GERMANY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 69
GERMANY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 70
GERMANY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 71
GERMANY: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 72
FRANCE: KEY MACROINDICATORS
TABLE 73
FRANCE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 74
FRANCE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 75
FRANCE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 76
FRANCE: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 77
UK: KEY MACROINDICATORS
TABLE 78
TOTAL NUMBER OF PATIENTS ON ACTIVE ORGAN TRANSPLANT WAITING LIST IN UK (AS OF APRIL 8, 2021)
TABLE 79
UK: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 80
UK: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 81
UK: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 82
UK: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 83
SPAIN: KEY MACROINDICATORS
TABLE 84
SPAIN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 85
SPAIN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 86
SPAIN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 87
SPAIN: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 88
ITALY: KEY MACROINDICATORS
TABLE 89
ITALY: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 90
ITALY: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 91
ITALY: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 92
ITALY: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 93
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 94
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 95
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 96
REST OF EUROPE: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 97
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 99
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 100
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 101
ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 102
CHINA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 103
CHINA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 104
CHINA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 105
CHINA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 106
TOTAL NUMBER OF PATIENTS ON ORGAN TRANSPLANT WAITING LIST IN JAPAN (AS OF MARCH 31, 2021)
TABLE 107
JAPAN: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 108
JAPAN: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 109
JAPAN: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 110
JAPAN: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 111
INDIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 112
INDIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 113
INDIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 114
INDIA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 115
AUSTRALIA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 116
AUSTRALIA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 117
AUSTRALIA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 118
AUSTRALIA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 119
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 120
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 121
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 122
SOUTH KOREA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 123
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 124
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 125
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 126
REST OF ASIA PACIFIC: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 127
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 129
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 130
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 131
LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 132
BRAZIL: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 133
BRAZIL: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 134
BRAZIL: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 135
BRAZIL: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 136
MEXICO: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 137
MEXICO: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 138
MEXICO: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 139
MEXICO: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 140
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 141
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 142
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 143
REST OF LATIN AMERICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 144
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 145
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 146
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 147
MIDDLE EAST & AFRICA: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 148
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)
TABLE 149
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY SOLUTION, 2023–2030 (USD MILLION)
TABLE 150
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2023–2030 (USD MILLION)
TABLE 151
GCC COUNTRIES: ORGAN PRESERVATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 152
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ORGAN PRESERVATION MARKET
TABLE 153
ORGAN PRESERVATION MARKET: DEGREE OF COMPETITION
TABLE 154
ORGAN PRESERVATION MARKET: SOLUTION FOOTPRINT
TABLE 155
ORGAN PRESERVATION MARKET: TECHNIQUE FOOTPRINT
TABLE 156
ORGAN PRESERVATION MARKET: END USER FOOTPRINT
TABLE 157
ORGAN PRESERVATION MARKET: REGION FOOTPRINT
TABLE 158
ORGAN PRESERVATION MARKET: LIST OF KEY STARTUPS/SMES
TABLE 159
ORGAN PRESERVATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 160
ORGAN PRESERVATION MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JUNE 2025
TABLE 161
ORGAN PRESERVATION MARKET: DEALS, JANUARY 2021–JUNE 2025
TABLE 162
ORGAN PRESERVATION MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
TABLE 163
PARAGONIX TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 164
PARAGONIX TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 165
PARAGONIX TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025
TABLE 166
PARAGONIX TECHNOLOGIES, INC.: DEALS, JANUARY 2021–MAY 2025
TABLE 167
PARAGONIX TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2025
TABLE 168
XVIVO PERFUSION AB: COMPANY OVERVIEW
TABLE 169
XVIVO PERFUSION AB: PRODUCTS OFFERED
TABLE 170
XVIVO PERFUSION AB: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 171
XVIVO PERFUSION AB: DEALS, JANUARY 2021–MAY 2025
TABLE 172
DR. FRANZ KÖHLER CHEMIE GMBH: COMPANY OVERVIEW
TABLE 173
DR. FRANZ KÖHLER CHEMIE GMBH: PRODUCTS OFFERED
TABLE 174
ESSENTIAL PHARMACEUTICALS, LLC: COMPANY OVERVIEW
TABLE 175
ESSENTIAL PHARMACEUTICALS, LLC: PRODUCTS OFFERED
TABLE 176
TRANSMEDICS, INC.: COMPANY OVERVIEW
TABLE 177
TRANSMEDICS, INC.: PRODUCTS OFFERED
TABLE 178
TRANSMEDICS, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 179
TRANSMEDICS, INC.: DEALS
TABLE 180
ORGANOX LIMITED: COMPANY OVERVIEW
TABLE 181
ORGANOX LIMITED: PRODUCTS OFFERED
TABLE 182
ORGANOX LIMITED: PRODUCT LAUNCHES & APPROVALS
TABLE 183
ORGANOX LIMITED: DEALS
TABLE 184
21ST CENTURY MEDICINE: COMPANY OVERVIEW
TABLE 185
21ST CENTURY MEDICINE: PRODUCTS OFFERED
TABLE 186
BIOLIFE SOLUTIONS, INC.: COMPANY OVERVIEW
TABLE 187
BIOLIFE SOLUTIONS, INC.: PRODUCTS OFFERED
TABLE 188
BIOLIFE SOLUTIONS, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025
TABLE 189
BIOLIFE SOLUTIONS, INC.: DEALS, JANUARY 2021–MAY 2025
TABLE 190
BRIDGE TO LIFE LIMITED: COMPANY OVERVIEW
TABLE 191
BRIDGE TO LIFE LIMITED: PRODUCTS OFFERED
TABLE 192
BRIDGE TO LIFE LIMITED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2025
TABLE 193
BRIDGE TO LIFE LIMITED: DEALS, JANUARY 2021–MAY 2025
TABLE 194
WATERS MEDICAL SYSTEMS LLC: COMPANY OVERVIEW
TABLE 195
WATERS MEDICAL SYSTEMS LLC: PRODUCTS OFFERED
FIGURE 1
ORGAN PRESERVATION MARKET: RESEARCH DESIGN
FIGURE 2
LIST OF PRIMARY SOURCES
FIGURE 3
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7
REVENUE SHARE ANALYSIS ILLUSTRATION: XVIVO PERFUSION AB (2024)
FIGURE 8
ILLUSTRATIVE EXAMPLE OF PROCEDURE-BASED MARKET ESTIMATION
FIGURE 9
SUPPLY-SIDE MARKET SIZE ESTIMATION: ORGAN PRESERVATION MARKET (2024)
FIGURE 10
TOP-DOWN APPROACH
FIGURE 11
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGAN PRESERVATION MARKET (2025–2030)
FIGURE 12
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13
DATA TRIANGULATION METHODOLOGY
FIGURE 14
ORGAN PRESERVATION MARKET, BY SOLUTION, 2025 VS. 2030 (USD MILLION)
FIGURE 15
ORGAN PRESERVATION MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)
FIGURE 16
ORGAN PRESERVATION MARKET, BY ORGAN TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17
ORGAN PRESERVATION MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18
GEOGRAPHIC ANALYSIS OF ORGAN PRESERVATION MARKET
FIGURE 19
RISING NUMBER OF SOLID ORGAN TRANSPLANTS TO DRIVE ORGAN PRESERVATION MARKET
FIGURE 20
UNIVERSITY OF WISCONSIN SOLUTION AND CHINA SEGMENTS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ORGAN PRESERVATION MARKET IN 2024
FIGURE 21
CHINA TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 22
NORTH AMERICA TO DOMINATE ORGAN PRESERVATION MARKET TILL 2030
FIGURE 23
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 24
ORGAN PRESERVATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25
ORGAN PRESERVATION MARKET: ECOSYSTEM ANALYSIS
FIGURE 26
ORGAN PRESERVATION MARKET: VALUE CHAIN ANALYSIS
FIGURE 27
SUPPLY CHAIN ANALYSIS: ORGAN PRESERVATION MARKET (2024)
FIGURE 28
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ORGAN PRESERVATION SOLUTIONS (JANUARY 2014–APRIL 2025)
FIGURE 29
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ORGAN PRESERVATION PATENTS, 2014–2025
FIGURE 30
ORGAN PRESERVATION MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 SOLUTIONS
FIGURE 32
KEY BUYING CRITERIA FOR TOP 3 SOLUTIONS
FIGURE 33
TRENDS AND DISRUPTIONS DISRUPTING CUSTOMER BUSINESS IN ORGAN PRESERVATION MARKET
FIGURE 34
ORGAN PRESERVATION MARKET: INVESTMENT AND FUNDING SCENARIO, 2021–2024
FIGURE 35
ORGAN PRESERVATION MARKET: AI INTEGRATION
FIGURE 38
ASIA PACIFIC: ORGAN PRESERVATION MARKET SNAPSHOT
FIGURE 39
REVENUE ANALYSIS OF KEY PLAYERS IN ORGAN PRESERVATION MARKET (2021−2024)
FIGURE 40
MARKET SHARE ANALYSIS OF KEY PLAYERS (2024)
FIGURE 41
ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 42
ORGAN PRESERVATION MARKET: COMPANY FOOTPRINT
FIGURE 43
ORGAN PRESERVATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 44
YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 45
EV/EBITDA OF KEY VENDORS
FIGURE 46
ORGAN PRESERVATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 47
XVIVO PERFUSION AB: COMPANY SNAPSHOT (2024)
FIGURE 48
TRANSMEDICS, INC.: COMPANY SNAPSHOT (2024)
FIGURE 49
BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT (2024)
Marta
May, 2022
We have an investigation at the University on Organ Preservation Market and we want to analyze if it has potential. Thank you.
Benjamin
May, 2022
Interest in the organ preservation market, specifically organ preservation solutions.
Jacob
Oct, 2022
I want more detailed information on the market size estimation methodologies followed for the study of Organ Preservation Market.